Inhibition of CHK1 sensitizes Ewing sarcoma cells to the ribonucleotide reductase inhibitor gemcitabine

Overview of attention for article published in Oncotarget, June 2017

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 1 X post from an account with 938 followers.

My life last year in 16 pages. https://t.co/i3Yms4f6X6

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.